Menarini-Stemline Industry Symposium

XPO-1 inhibitors in myeloma: where do we stand?
Saturday, May 13, 2023
09:10–09:55 CEST
Agenda
09:10-09:30 | Pre-clinical evidence for the use of XPO-1 inhibitors in myeloma R. Rahme, Paris, France |
09:30-09:50 | Selinexor: the latest clinical data M. Mohty; Paris, France |